Regional Anesthesia in Patients on Antithrombotic Drugs: ESAIC-ESRA 2022 Guidelines

Performing regional anesthesia (RA) in patients on antithrombotic therapy poses a significant challenge due to the increased risk of bleeding complications, including spinal or epidural hematomas. Neuraxial and deep peripheral nerve blocks can lead to catastrophic consequences if performed without appropriate timing and management of anticoagulant and antiplatelet medications. The latest joint guidelines from the European Society of Anesthesiology and Intensive Care (ESAIC) and the European Society of Regional Anesthesia (ESRA) provide evidence-based recommendations to reduce these risks and guide anesthetists in making safe and informed decisions.Where else to find us:Web-⁠⁠http://www.nysora.com⁠⁠ Instagram-⁠⁠instagram.com/nysora.inc/ ⁠⁠LinkedIN-⁠⁠linkedin.com/company/nysora-inc/⁠⁠ Facebook-⁠⁠facebook.com/nysora⁠⁠ Twitter-⁠⁠x.com/nysora⁠⁠ TikTok-⁠⁠tiktok.com/@nysora_inc⁠⁠---------------------------------------------------------⁠⁠#nysora⁠⁠⁠⁠#regionalanesthesia⁠⁠⁠⁠#anesthesia⁠⁠Disclaimer: Medicine is an ever-changing science. As new research and clinical experience broaden, changes in treatment and drug therapy are required. The authors and publishers have checked with sources believed to be reliable in efforts to provide accurate information within the available or accepted standards of care. However, given the possibility of human error or changes in medical practice, neither the authors nor the publisher, nor any other party involved in the preparation of this platform warrants that the information contained herein is in every aspect accurate or complete, and they disclaim all responsibility for any errors or omissions for the results obtained from the use of the information contained in this work. Readers are advised to confirm the information contained herein with other sources. For example, readers are advised to check the product information of each drug mentioned, and that any information contained on NYSORA's Podcast is accurate.